Baird Medical Investment Holdings Ltd., a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a global leader in microwave ablation (MWA) technology, has received regulatory approval from the Indonesian Ministry of Health (Kementerian Kesehatan Republik Indonesia). This approval includes the Great Wall Microwave Therapeutic Instrument and the Great Wall Disposable Microwave Ablation Needle, laying the foundation for Baird Medical to introduce its advanced minimally invasive treatment solutions across Indonesia.
Health Technology Insights: Spark Biomedical Gets Health Canada Ok for Sparrow Ascent Withdrawal Device
“This regulatory approval marks a significant step in our global strategic expansion and underscores our commitment to improving patient care with cutting-edge, minimally invasive technologies,” said Haimei Wu, Chairwoman of Baird Medical. “We look forward to collaborating with Indonesian healthcare providers and supporting them with innovative solutions that enhance precision, safety, and patient outcomes.
Health Technology Insights: Serotonin Centers Adds NAD+ Therapy to Anti-aging Treatments
Microwave ablation is a highly effective, minimally invasive procedure that uses targeted microwave energy to destroy abnormal tissue with minimal impact on surrounding areas. Recognized for its precision and faster recovery times, MWA is widely used for treating conditions such as thyroid nodules and tumors.
With this regulatory milestone, Baird Medical is set to expand its distribution network and collaborate with key medical institutions in Indonesia, reinforcing its commitment to bringing next-generation medical solutions to emerging markets.
Health Technology Insights: Philips Chooses AWS as Preferred Cloud to Drive Innovation, Patient Care
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – PR Newswire
